Evidence map›Paper›PMID 41860823›Full record

ArticlePloS one2026

A theoretical and experimental model of flow characteristics in subretinal injections.

Reza Ladha, Benjamin Merveille, Roland Wyns, Benoit Scheid, François Willermain, Marc D de Smet

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Reza LadhaDepartments of Ophthalmology, CHU Saint-Pierre and CHU Brugmann, Brussels, Belgium.ORCID https://orcid.org/0000-0002-9439-9256
Benjamin MerveilleBiomedical Department, CHU Saint-Pierre, Brussels, Belgium.
Roland WynsBiomedical Department, CHU Saint-Pierre, Brussels, Belgium.
Benoit ScheidTIPs-μfluidics, Université Libre de Bruxelles, Brussels, Belgium.
François WillermainDepartments of Ophthalmology, CHU Saint-Pierre and CHU Brugmann, Brussels, Belgium.
Marc D de SmetUniversité Libre de Bruxelles, Brussels, Belgium.ORCID https://orcid.org/0000-0002-9217-5603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subretinal injections (SI) are used to deliver gene therapies for inherited retinal diseases, yet the optimal injection parameters remain undefined. This study used theoretical and experimental models to quantify the relationship between injection pressure, flow dynamics, and residual flow. A theoretical model (TM) was developed based on the Hagen-Poiseuille law and the theory of a jet immersed in the same liquid. An experimental model (EM) was constructed to allow for measuring flow and residual flow across injection pressures ranging from 0 to 20 psi. We assessed the effects of ambient pressure, injection system tubing length, and syringe priming technique. A minimum pressure of 6 psi was required to generate a detectable flow in the EM. Jet speed increased with the square root of injection pressure, aligning with theoretical predictions. Residual flow persisted for 28-47 seconds after injection and increased logarithmically with injection pressure. Elevated ambient pressure (45 mmHg) only reduced flow at lower injection pressures. The "lock-and-load" priming method decreased jet speed and increased residual flow compared to the "load-and-lock" method. Both TM and EM quantified SI flow dynamics, with EM demonstrating residual flow at all tested pressures. To minimize complications, clinicians should use the lowest injection pressure and allow sufficient time for the cannula to be withdrawn from the subretinal space.

Indexed as

Genetic TherapyModels, TheoreticalRetinaAnimalsHumansInjections, IntraocularPressure

Identifiers

PMID41860823
PMCPMC13004354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.